Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank44
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P44
Within normal range
Average
-566.49%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%-
20230.00%-
20220.00%+100.0%
2021-183.40%+92.5%
2020-2452.53%+9.2%
2019-2700.87%-658.8%
2018-355.92%-37553.3%
20130.95%-96.5%
201226.92%-